Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 2/20 | 0.49 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.49 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.49 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA7 | P43166 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.47 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4960422 | 0.85 | LTA4H (0.53) | PDE4APDE4BPDE4CPDE4DALDH1A1 | |
| SCHEMBL3026188 | 0.84 | CALM1 (0.51) | PDE4APDE4BPDE4CPDE4DCALM1 | |
| SCHEMBL19433111 | 0.83 | LTA4H (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2319036 | 0.83 | ALDH1A1 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL19433121 | 0.82 | LTA4H (0.52) | ALDH1A1MEN1KMT2ALTA4HESR1 | |
| SCHEMBL3717467 | 0.81 | ESR1 (0.54) | PDE4APDE4BPDE4CPDE4DCA12 | |
| SCHEMBL3066802 | 0.81 | TRPA1 (0.48) | PDE4APDE4BPDE4CPDE4DALDH1A1 | |
| SCHEMBL29756063 | 0.81 | ESR1 (0.54) | PDE4APDE4BPDE4CPDE4DCA12 | |
| SCHEMBL19433097 | 0.80 | NR5A1 (0.55) | MEN1KMT2ALTA4HESR1TYR | |
| SCHEMBL2221183 | 0.79 | MAPT (0.50) | CALM1ALDH1A1MEN1KMT2ALTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5151458-A | Molding materials for liquid crystal resins | BAYER AKTIENGESELLSCHAFT (DE) | 1992-09-29 | — | — | US | claimed |
| US-5143956-A | Blends with low molecular weight liquid crystals | BAYER AKTIENGESELLSCHAFT (DE) | 1992-09-01 | — | — | US | claimed |
| US-5102935-A | With low molecular weight, liquid crystalline esters and/or ester amides | BAYER AKTIENGESELLSCHAFT (DE) | 1992-04-07 | — | — | US | claimed |
| EP-0464351-A2 | Polycarbonate, polyestercarbonate and polyester moulding compositions with high melt flow | BAYER AG (DE) | 1992-01-08 | — | — | EP | claimed |
| EP-0444295-A1 | Low-viscosity polyamide mouldings | BAYER AG (DE) | 1991-09-04 | — | — | EP | claimed |
| EP-0444292-A2 | Easy fluoring polyamide moulding compositions | BAYER AG (DE) | 1991-09-04 | — | — | EP | claimed |
| EP-0398052-A2 | Low-viscosity polyarylene sulfide mouldings | BAYER AG (DE) | 1990-11-22 | — | — | EP | claimed |
| EP-0359037-A2 | Low-viscosity polyamide mouldings and mixtures | BAYER AG (DE) | 1990-03-21 | — | — | EP | claimed |
| US-11129781-B2 | Agent for hair deforming treatment | KAO CORPORATION (JP) | 2021-09-28 | — | — | US | disclosed |
| US-11045402-B2 | Hair cosmetic composition | KAO CORPORATION (JP) | 2021-06-29 | — | — | US | disclosed |
| US-10959925-B2 | Hair cosmetic composition | KAO CORPORATION (JP) | 2021-03-30 | — | — | US | disclosed |
| EP-3228302-B1 | HAIR DEFORMATION TREATMENT AGENT | KAO CORP (JP) | 2020-09-02 | — | — | EP | disclosed |
| CN-106999382-B | Hair deforming agent | 花王株式会社 | 2020-07-10 | — | — | CN | disclosed |
| CN-106999380-B | Hair deforming agent | 花王株式会社 | 2020-05-05 | — | — | CN | disclosed |
| EP-0232777-A2 | Method of manufacturing parts of thermotropic liquid crystalline plastics with a defined orientation of the liquid crystal polymer molecule, and the parts so produced | BAYER AG (DE) | 1987-08-19 | — | — | EP | disclosed |
| US-4599395-A | Thermotropic, aromatic polyesters having good mechanical strength, containing sulfonic acid groups or metal sulfonate groups a process for the production thereof | BAYER AKTIENGESELLSCHAFT (DE) | 1986-07-08 | — | — | US | disclosed |
| EP-0141320-A2 | Thermotropic aromatic polyesters with high stiffness, process for their production and their use in the production of moulded articles, filaments, fibres and films | BAYER AG (DE) | 1985-05-15 | — | — | EP | disclosed |
| EP-0024499-B1 | BIAXIALLY ORIENTED WHOLLY AROMATIC POLYESTER FILM AND PROCESS FOR PRODUCING SAME | TEIJIN LIMITED (JP) | 1984-03-07 | — | — | EP | disclosed |
| US-4333907-A | Biaxially oriented wholly aromatic polyester film | TEITIN LIMITED (JP) | 1982-06-08 | — | — | US | disclosed |
| EP-0024499-A1 | Biaxially oriented wholly aromatic polyester film and process for producing same | TEIJIN LIMITED (JP) | 1981-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11045402-B2 | Hair cosmetic composition | CUTA, GRHPR, POLR1C | PDE4A 3452/4885PDE4B 4014/4885PDE4C 3500/4885 |
| US-10959925-B2 | Hair cosmetic composition | CUTA, POLR1C, GRHPR | PDE4A 4123/4885PDE4B 4400/4885PDE4C 3859/4885 |
| US-11129781-B2 | Agent for hair deforming treatment | GRHPR, SLC26A4, COL1A1 | PDE4A 1354/4885PDE4B 1463/4885PDE4C 1257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.